Vaxcyte Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2017 | — | — | $36.1M |
| Dec 2018 | — | — | $66.1M |
| Jun 2019 | — | — | $42.5M |
| Sep 2019 | — | — | $33.3M |
| Dec 2019 | $11.8M | $65.7M | $59.0M |
| Mar 2020 | — | — | $154.8M |
| Jun 2020 | $33.0M | $416.2M | $410.0M |
| Sep 2020 | $39.7M | $403.8M | $397.0M |
| Dec 2020 | $47.0M | $392.8M | $386.2M |
| Mar 2021 | $55.4M | $382.4M | $198.9M |
| Jun 2021 | $41.0M | $358.1M | $151.0M |
| Sep 2021 | $48.1M | $354.1M | $112.0M |
| Dec 2021 | $40.3M | $324.3M | $69.0M |
| Mar 2022 | $43.2M | $402.7M | $201.7M |
| Jun 2022 | $45.1M | $411.6M | $238.2M |
| Sep 2022 | $52.8M | $412.1M | $278.4M |
| Dec 2022 | $52.6M | $1.01B | $834.7M |
| Mar 2023 | $63.4M | $1.01B | $380.5M |
| Jun 2023 | $69.4M | $1.50B | $531.0M |
| Sep 2023 | $93.3M | $1.50B | $545.1M |
| Dec 2023 | $167.4M | $1.41B | $397.5M |
| Mar 2024 | $107.3M | $2.09B | $611.5M |
| Jun 2024 | $101.1M | $2.09B | $518.7M |
| Sep 2024 | $142.1M | $3.56B | $1.05B |
| Dec 2024 | $205.5M | $3.51B | $387.9M |
| Mar 2025 | $178.1M | $3.38B | $346.9M |
| Jun 2025 | $234.0M | $3.31B | $306.7M |
| Sep 2025 | $278.7M | $3.17B | $281.1M |
| Dec 2025 | $317.2M | $3.00B | $174.0M |
| Mar 2026 | $352.3M | $3.35B | $260.8M |
| Jun 2026 | $380.2M | $3.14B | $183.2M |